Inicio › Linfoma folicular › Tennessee › Nashville
Ensayos clínicos de Linfoma folicular en Nashville, TN
18 estudios para Linfoma folicular buscan participantes en centros de Nashville y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
ReclutandoFase 1/2
- Tennessee Oncology, Pllc Nashville, Nashville
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
ReclutandoFase 1
- Sarah Cannon Research Institute - Pharmacy, Nashville
- SCRI Oncology Partners, Nashville
A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)
ReclutandoFase 2/3
- SCRI Oncology Partners ( Site 7000), Nashville
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
ReclutandoFase 1/2
- SCRI Oncology Partners ( Site 0100), Nashville
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
ReclutandoFase 1
- SCRI Oncology Partners, Nashville
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
ReclutandoFase 1
- Sarah Cannon Research Institute, Nashville
- Vanderbilt University Medical Center, Nashville
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
ReclutandoFase 3
- Research Site, Nashville
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
ReclutandoFase 2
- Research Site, Nashville
Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
ReclutandoFase 3
- Tennessee Oncology, Nashville
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
ReclutandoFase 3
- Vanderbilt University Medical Center, Nashville
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
ReclutandoFase 1
- Vanderbilt University/Ingram Cancer Center, Nashville
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
ReclutandoFase 3
- Vanderbilt-Ingram Cancer Center, Nashville
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
ReclutandoFase 1/2
- Vanderbilt University Medical Center, Nashville
Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder
ReclutandoFase 2
- Vanderbilt University Medical Center, Nashville
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
ReclutandoFase 1/2
- TriStar BMT, Nashville
This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma
ReclutandoFase 1
- Tennessee Oncology, Nashville
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
ReclutandoFase 1
- Tennessee Oncology, Nashville
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ReclutandoEstudio observacional
- Massive Bio SYNERGY-AI site, Nashville
Ensayos de Linfoma folicular en otras ciudades
- New York City, NY24 estudios
- Milwaukee, WI19 estudios
- Houston, TX18 estudios
- Boston, MA17 estudios
- Baldwin Park, CA16 estudios
- Seattle, WA15 estudios
- Durham, NC15 estudios
- Columbus, OH13 estudios
- Salt Lake City, UT13 estudios
- Chicago, IL12 estudios
- San Antonio, TX12 estudios
- Philadelphia, PA12 estudios
Otros estudios en Nashville
- Cáncer de pulmón de células no pequeñas97 estudios
- Cáncer de seno81 estudios
- Cáncer metastásico70 estudios
- Cáncer del colon y del recto69 estudios
- Cáncer (todos los tipos)65 estudios
- Cáncer de ovario49 estudios
- Cáncer de próstata43 estudios
- Cáncer de pulmón40 estudios
- Carcinoma de células escamosas de cabeza y cuello39 estudios
- Cáncer de páncreas39 estudios
- Cáncer de endometrio38 estudios
- Melanoma33 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.